Terms: = Gastric cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
8 results:
1. Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis.
Xing X; Shi J; Jia Y; Dou Y; Li Z; Dong B; Guo T; Cheng X; Li X; Du H; Hu Y; Jia S; Zhang J; Li Z; Ji J
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35361730
[TBL] [Abstract] [Full Text] [Related]
2. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract] [Full Text] [Related]
3. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
[TBL] [Abstract] [Full Text] [Related]
4. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
Lin SJ; Gagnon-Bartsch JA; Tan IB; Earle S; Ruff L; Pettinger K; Ylstra B; van Grieken N; Rha SY; Chung HC; Lee JS; Cheong JH; Noh SH; Aoyama T; Miyagi Y; Tsuburaya A; Yoshikawa T; Ajani JA; Boussioutas A; Yeoh KG; Yong WP; So J; Lee J; Kang WK; Kim S; Kameda Y; Arai T; Zur Hausen A; Speed TP; Grabsch HI; Tan P
Gut; 2015 Nov; 64(11):1721-31. PubMed ID: 25385008
[TBL] [Abstract] [Full Text] [Related]
5. Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer.
Okita Y; Tanaka H; Ohira M; Muguruma K; Kubo N; Watanabe M; Fukushima W; Hirakawa K
J Surg Res; 2014 Jan; 186(1):192-200. PubMed ID: 24120241
[TBL] [Abstract] [Full Text] [Related]
6. Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer.
Kandulski A; Malfertheiner P; Wex T
Anticancer Res; 2010 Apr; 30(4):1093-103. PubMed ID: 20530414
[TBL] [Abstract] [Full Text] [Related]
7. Localisation pattern of foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Br J Cancer; 2008 Jan; 98(1):148-53. PubMed ID: 18087278
[TBL] [Abstract] [Full Text] [Related]
8. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.
Kono K; Kawaida H; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Fujii H
Cancer Immunol Immunother; 2006 Sep; 55(9):1064-71. PubMed ID: 16328385
[TBL] [Abstract] [Full Text] [Related]
